baber/WOPTO huggingface dataset:
Patent AU-2018264076-A1 (AU)
Title: Turbine with dynamically adaptable savonius blades
Inventor: MOHAJER HASSAN
IPC: F03D3/06
Filed: 2018-11-15
Abstract: Abstract An apparatus may include a cage that rotates around a cage axis and a turbine located at an end of the cage and rotating around a turbine axis. A turbine blade may have an adaptable shape. A frame of the turbine blade may have a first frame portion that pivots relative to the second frame portion. The curvature of the turbine blade may be controlled by shortening a connection while concurrently lengthening another connection. Controllers may control the rotation of the cage(s) and/or turbine(s) based on a speed, a direction, a velocity, an acceleration of wind, and/or a load carried by the apparatus. The apparatus may be a Savonius machine. Rotation of the cage(s) and/or turbine(s) may induce a Magnus effect. A seat and user controls near the seat may be included. The user controls may control the rotation of the cage(s) and/or turbine(s). 180 114 164 1 4142 124 116 .... 191 .... 8 166 10192
Patent AU-2018329951-A1 (AU)
Title: Process for the preparation of tubulysins and intermediates thereof
Inventor: WU KUN-LIANG
IPC: C07H15/26
Filed: 2018-09-07
Abstract: Improved processes for the preparation of tubulysin compounds, tubulysin drug linker compounds, and their intermediates are disclosed.
Patent AU-2018338277-A1 (AU)
Title: Composition for promoting energy consumption
Inventor: MATSUNAGA YUTAKA
IPC: A61P3/00
Filed: 2018-03-23
Abstract: Provided is a technique for promoting the consumption of energy. A composition for promoting the consumption of energy, which contains, as an active ingredient, a milk protein hydrolysate having an average molecular weight of 220 to 1000 dalton inclusive, or a peptide comprising Met-Lys-Pro or a peptide comprising the amino acid sequence.
Patent AU-2018341349-A1 (AU)
Title: Soil application of crop protection agents
Inventor: AVGOUSTI MARIOS
IPC: C05G3/00
Filed: 2018-09-25
Abstract: The disclosure relates to systems, compositions and methods for providing nutrients, root proliferants, crop protection agents and other crop inputs for a plant. The disclosure also relates to methods for increasing the uptake of a crop active compound into a growing plant.
Patent AU-2018356645-A1 (AU)
Title: Device for rearing aquaculture animals at sea
Inventor: MARISSAL ERIC
IPC: A01K61/54
Filed: 2018-10-26
Abstract: The device (1) comprises: - a framework (3); - at least one rearing enclosure (5) internally delimiting a volume (7) for receiving the aquaculture animals (9); - a float device (10) connected to said at least one rearing enclosure (5); - a connection (13) connecting said at least one rearing enclosure (5) to the framework (3), permitting a rotation of said at least one rearing enclosure (5) with respect to the framework (3) about at least one substantially horizontal axis of rotation; - a limiter device (86) limiting the clearance of said at least one rearing enclosure (5) with respect to the framework (3) in the vertical direction.
Patent AU-2018379804-A1 (AU)
Title: Surfactant supply systems
Inventor: BALDUCCHI-PRINCE FRANCK ERNEST CLAUDE
IPC: A01M21/04
Filed: 2018-12-07
Abstract: A system (10) for providing a stream of water that includes a surfactant, comprising a source (14) of water, means (32) to cause water to flow along a water supply duct (34), and a venturi injector (36) within the water supply duct. The venturi injector (36) communicates with an inlet duct (77) to supply surfactant; and the system comprises a surfactant supply duct (80, 83) that communicates between the inlet duct (77) and a surfactant container (18), the surfactant supply duct comprising a first portion that incorporates an on/off valve (38) and a second portion (83) that incorporates a check valve (84) to control flow. A plurality of surfactant containers (18) may be connected to the inlet duct (77) in this way; and each surfactant container 18 may be mounted within an open-topped chamber (68) to which hot water may be provided to heat the contents of the surfactant container (18).
Patent AU-2018399939-A1 (AU)
Title: Semi-solid dosage form for topical application
Inventor: MO Y JOSEPH
IPC: A61K9/107
Filed: 2018-12-06
Abstract: It relates to topical dosage forms for topical application on skin for selective absorption by the skin tissue, particularly for administration of medicinal agents where a localized systemic application is desirable for medicines such as but not limited to glucosamine. In particular, it relates to pharmaceutical formulation of osteoarthritis drugs in the class of hexosamines or in combination of one or more nonnarcotic analgesics.
Patent AU-2018404213-A1 (AU)
Title: Auxiliary system and method for starting or restarting the flow of gelled fluid
Inventor: DOS SANTOS VIEIRA LIMA GUILHERME
IPC: F16L55/053
Filed: 2018-01-25
Abstract: The present invention relates to an auxiliary system for starting or restarting the flow of gelled fluid contained in a pipeline (12) wherein the system comprises: at least one relief tank (13) fluidly connected (11) to the pipeline (12), wherein at least one relief tank (13) is suitable for receiving fluid from the pipeline (12); and at least one pressurising element upstream of at least one tank, suitable for pressurising the fluid in the pipeline (12). Additionally, the invention also provides an auxiliary method for starting or restarting the flow of gelled fluid in a pipeline (12) comprising at least one tank fluidly connected (11) to the pipeline (12) and at least one pressurising element upstream of at least one tank, wherein the method comprises the step of, at the start of the process, the pressurising element increasing the pressure in the pipeline (12) and filling at least one tank at least partially with fluid coming from the pipeline (12).
Patent AU-2018426555-A1 (AU)
Title: Silicon pole plate and preparation method therefor, use of silicon in fuel cell, fuel cell stack structure, fuel cell and use thereof
Inventor: SHI ZHENGRONG
IPC: H01M8/24
Filed: 2018-06-26
Abstract: Disclosed are a silicon pole plate and a preparation method therefor, the use of silicon in a fuel cell, a fuel cell stack structure, a fuel cell and the use thereof, wherein the silicon pole plate is made by using a doped conductive crystalline silicon material, and has an interior cooling medium flow passage, a front reductant flow passage and/or a back oxidant flow passage, and the interior cooling medium flow passage, the front reductant flow passage and/or the back oxidant flow passage are respectively provided with a combination of an inlet and outlet of the silicon pole plate, which are in communication therewith. Compared with a metal pole plate, a graphite pole plate or a composite material pole plate in the prior art, the silicon pole plate proposed by the present invention has better advantages in terms of lifespan, cost, efficiency and power density, which undoubtedly has a great significance for and a core role in promoting the mass industrialization process of fuel cells.
Patent WO-2020023993-A1 (WO)
Title: System and process for removing polyfluorinated pollutants from water
Inventor: LEGG RICKY
IPC: C02F1/28
Filed: 2019-07-31
Abstract: A water treatment system is disclosed. The water treatment system comprises a filtration module comprising one or more ultrafiltration membrane configured to remove one or more non-PFAS contaminant from a PFAS contaminated water stream to provide a partially purified water stream containing soluble PFAS contaminants. The water treatment system also comprises a sorption module comprising one or more sorption units comprising a sorbent material, the sorption module being in fluid communication with the filtration module and downstream therefrom and configured to remove substantially all PFAS contaminants from the partially purified water stream to provide purified water that is substantially free from PFAS contamination.
Patent WO-2019183670-A1 (WO)
Title: A system for mounting a service component to a building structure
Inventor: GORDON STUART
IPC: F24S25/00
Filed: 2019-03-26
Abstract: A system for mounting a service component to a building structure has a plurality of elongate feet, and a plurality of connectors that each interconnect a respective one of the feet with the service component. Each foot is configured to affix to a surface of the building structure and then to resist disengagement from that surface. The connectors each interconnect a respective one of the feet with the service component, and secure the relative position of the respective foot and the service component. An elongate beam can be connected or connectable to the service component, such that in the installed system the beam is to be positioned to extend obliquely across the feet.
Patent AU-2019201229-A1 (AU)
Title: Perovskite material layer processing
Inventor: IRWIN MICHAEL D
IPC: H01L51/00
Filed: 2019-02-21
Abstract: A method for processing a perovskite photoactive layer comprising: depositing a lead salt precursor onto a substrate to form a lead salt thin film; depositing a second salt precursor onto the lead salt thin film; and annealing the substrate to form a perovskite material, wherein annealing occurs in a controlled humidity environment at an absolute humidity greater than or equal to 0 g H20/m3 air and less than or equal to 20 g H20/m3 air. Methods of depositing salt precursors include spin coating, slot-die printing, sputtering, PE-CVD, thermal evaporation, or spray coating. WO 2017/011239 PCT/US2016/041090 -O Glas N -1502 -1503 -1504 Cye FT,97, _-1507 Glass Fig. 1 Glass 77-1502 -1601 0 --- 1505 / Zz -7-1506 Glass Fig. 2
Patent AU-2019204979-A1 (AU)
Title: Endoglin polypeptides and uses thereof
Inventor: GRINBERG ASYA
IPC: C07K14/515
Filed: 2019-07-11
Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis related disorders.
Patent AU-2019204982-A1 (AU)
Title: Recombinant HCMV and RhCMV Vectors and Uses Thereof
Inventor: PICKER LOUIS
IPC: A61K39/12
Filed: 2019-07-11
Abstract: Described herein are recombinant rhesus cytomegalovirus (RhCMV) and human cytomegalovirus (HCMV) vectors encoding heterologous antigens, such as pathogen-specific antigens or tumor antigens. The recombinant vectors elicit and maintain high level cellular and humoral immune responses specific for the heterologous antigen. The recombinant RhCMV and HCMV vectors may be used, for example, for the treatment or prevention of infectious disease or cancer. In some examples, the recombinant RhCMV or HCMV vectors may include deletions in genes encoding immunomodulatory proteins. In some examples, the recombinant RhCMV or HCMV vectors may be deficient or impaired in their ability to replicate within a cell, disseminate within the host or spread among hosts by including a deletion in one or more genes essential or augmenting for CMV replication, dissemination or spread.
Patent AU-2019211132-A1 (AU)
Title: Detecting objects submerged in a body of water or at least partly buried in a bed of the body of water
Inventor: CHABERT ANNE MARIE
IPC: G01S15/89
Filed: 2019-01-26
Abstract: The invention provides an apparatus (10, 14) for detecting objects that are submerged in a body of water or at least partly buried in a bed of the body of water. According to a first aspect, the apparatus comprises a support structure (16) adapted to be mounted to a remotely operated towed vehicle, ROTV (12),a plurality of acoustic transducers (27.x) mounted to the support structure (16), and at least one magnetic sensor (28.x) mounted to the support structure (16).According to a second aspect, the apparatus comprises a remotely operated towed vehicle, ROTV (12), the ROTV (12) comprising at least one control flap (38.x) operable to control a sub-surface depth of the ROTV (12) when the ROTV (12) is towed in the body of water,a support structure (16) mounted to the ROTV (12), and a plurality of acoustic transducers (27.x) mounted to the support structure (16).The invention further provides a method, a computer system, and a machine-readable medium.
Patent AU-2019217612-A1 (AU)
Title: Inhibitors of the Notch transcriptional activation complex kinase ("NACK") and methods for use of the same
Inventor: CAPOBIANCO ANTHONY J
IPC: A61P37/06
Filed: 2019-02-06
Abstract: Disclosed herein are Notch transcriptional activation complex kinase ("NACK") inhibitors, and methods for their use in treating or preventing diseases, such as cancer. The inhibitors described herein include compounds of Formula (la) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.
Patent AU-2019219240-A1 (AU)
Title: Psychophysical method to characterize visual symptoms
Inventor: ROSEN ROBERT
IPC: A61B3/032
Filed: 2019-02-08
Abstract: A psychophysical method, system, and apparatuses to characterize visual symptoms. A method may include presenting one or more stimuli to a patient indicating one or more visual symptoms. The patient may produce one or more responses to the stimuli. A determination of a measure of visual symptoms of the patient may be made utilizing a Bayesian method based on the responses.
Patent AU-2019223675-A1 (AU)
Title: Detergent solid composition comprising aminopolycarboxylate and organic acid
Inventor: ARLABOSSE HÉLÈNE JULIE MARIE
IPC: C11D3/20
Filed: 2019-02-12
Abstract: A solid composition comprising: a) from 25 to 88 wt.% free acid equivalent of non-crystalline chiral aminopolycarboxylate; and b) from 10 to 60 wt.% free acid equivalent of non-crystalline organic acid different from aminopolycarboxylate; and c) from 2 to 30 wt. % of water, wherein the pH of a solution made by dissolving the solid in water in a 1:1 weight ratio is at most 10.0, as measured at 25 degrees Celsius. Process for the manufacture of said solid composition, comprising the consecutive steps of: I) providing an aqueous solution comprising: a) free acid equivalent of chiral aminopolycarboxylate; and b) free acid equivalent of organic acid different from a), wherein the weight ratio of a):b) is from 1:2 to 8.8:1; and II) removing water from the aqueous solution by evaporation at a temperature of at least 50°C to produce a liquid desiccated mixture having a water content of from 2 to 30 wt.%; and III) reducing the temperature of the desiccated mixture to less than 25°C to obtain a solid composition. A unit dose detergent product comprising 1-90 wt.% of said solid composition, the unit dose detergent product preferably being a machine dish wash detergent product comprising 5 to 60 wt.% of surfactant. Use of said solid composition to provide a detergent product of which at least part thereof is translucent, preferably transparent and more preferably is also glossy.
Patent AU-2019239747-A1 (AU)
Title: Antibodies binding to VISTA at acidic pH
Inventor: JOHNSTON ROBERT J
IPC: C07K16/28
Filed: 2019-03-19
Abstract: The present application relates to antibodies specifically binding to the V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA) at acidic pH and their use in cancer treatment. In some embodiments, the antibodies bind specifically to human VISTA at acidic pH, but do not significantly bind to human VISTA at neutral or physiological pH.
Patent AU-2019242031-A1 (AU)
Title: Illumination for fluorescence imaging using objective lens
Inventor: SUN YINGHUA
IPC: G01N21/01
Filed: 2019-03-12
Abstract: A system includes: an objective lens; a first light source to feed first illuminating light through the objective lens and into a flowcell (e.g., with a relatively thin film waveguide) to be installed in the system, the first illuminating light to be fed using a first grating on the flowcell; and a first image sensor to capture imaging light using the objective lens, wherein the first grating is positioned outside a field of view of the first image sensor. Dual-surface imaging can be performed. Flowcells with multiple swaths bounded by gratings can be used. An auto-alignment process can be performed.
Patent AU-2019260099-A1 (AU)
Title: Methods to estimate the blood pressure and the arterial stiffness based on photoplethysmographic (PPG) signals
Inventor: LIZIO ROSARIO
IPC: A61B5/00
Filed: 2019-04-18
Abstract: The present invention relates to a method to estimate the blood pressure and the arterial stiffness based on photoplethysmographic (PPG) signals. New algorithms have been developed and validated based on PPG signals to analyze the cardiovascular condition of a person by estimating cardiovascular parameters. With the present invention a method for measuring one or more cardiovascular parameters in a subject based on PPG signals is provided.
Patent AU-2019284045-A1 (AU)
Title: Rack easy to assemble and disassemble
Inventor: CHENG CHUNXUAN
IPC: A47B47/00
Filed: 2019-12-23
Abstract: Provided is a rack easy to assemble and disassemble, comprising a front frame, 
a rear frame, and a number of shelves arranged between the front frame and the rear 
frame for placing articles thereon, wherein a number of supporting members for 
supporting the shelves are symmetrically distributed on the front frame and the rear 
frame, and the width of the shelves is slightly greater than that of the front frame and 
the rear frame. Compared with the prior art, the supporting members of the present 
invention for supporting the shelves are symmetrically distributed on the front frame 
and the rear frame, such that the shelves are directly placed on the supports on the 
front frame and the rear frame when in use, and the shelves can be removed from the 
supporting frames when the rack needs to be stored. The rack has a good bearing 
capacity, is easy to disassemble, assemble and use, and has a small package size after 
disassembly and is therefore convenient for storage.
119 
4 
2 
11 
4 
3 
1 
12 
61 
Fig. I
Patent AU-2019291568-A1 (AU)
Title: Systems and methods for determining structured proceeding outcomes
Inventor: SONG DEZHAO
IPC: G06Q50/18
Filed: 2019-06-19
Abstract: The present disclosure relates to systems and methods for analyzing and extracting data related to a structured proceeding, and for identifying, based on the analysis, at least one outcome associated with the structured proceeding. Embodiments provide for receiving data associated with a structured proceeding involving at least one party, the data including at least one docket entry, and analyzing, by an outcome location detector, the data to identify one or more docket entries in the at least one docket entry that are likely to include evidence of an outcome. Embodiments further include analyzing, by an outcome detector, the one or more docket entries determined to be likely to include evidence of an outcome to determine outcomes. The outcomes include at least one of a final outcome and at least one party outcome. The final outcome is associated with the structured proceeding overall, and the at least one party outcome is associated with a party of the at least one party that may have been terminated early.
Patent AU-2019333861-A1 (AU)
Title: Immunogenetic cancer screening test
Inventor: LISZEWICZ JULIANNA
IPC: G01N33/574
Filed: 2019-09-03
Abstract: The disclosure relates to a method for determining the risk that a human subject will develop a cancer, the method comprising quantifying the HLA triplets (HEAT) of the subject that are capable of binding to T cell epitopes in the amino acid sequence of tumor associated antigens. The disclosure also relates to methods of treating subjects who are determined to have an elevated risk of developing cancer.
Patent AU-2019334676-A1 (AU)
Title: Herv-K-derived antigens as shared tumor antigens for anti-cancer vaccine
Inventor: DEPIL STÉPHANE
IPC: A61K38/16
Filed: 2019-09-06
Abstract: A composition or vaccine comprising at least one peptide, or an expression vector that induces expression of said at least one peptide in vivo, the peptide consisting of, or comprising, shared HERV-K derived antigens, and a pharmaceutically acceptable vehicle or excipient. Composition comprising Cytotoxic T Lymphocytes (CTLs) of a patient treated with such a peptide, or comprising T-cell Receptor (TCR) engineered T cells recognizing such a peptide.
Patent AU-2019342099-A1 (AU)
Title: Therapeutic and diagnostic methods for bladder cancer
Inventor: MARIATHASAN SANJEEV
IPC: G01N33/574
Filed: 2019-09-17
Abstract: The present invention provides therapeutic and diagnostic methods and compositions for bladder cancer (e.g., a locally advanced or metastatic urothelial carcinoma). The invention provides methods of treating bladder cancer, methods of determining whether a patient suffering from bladder cancer is likely to respond to treatment comprising a PD-L1 axis binding antagonist, methods of predicting responsiveness of a patient suffering from bladder cancer to treatment comprising a PD-L1 axis binding antagonist, and methods of selecting a therapy for a patient suffering from bladder cancer, based on expression levels of a biomarker of the invention (e.g., PD-L1 expression levels in tumor-infiltrating immune cells in a tumor sample obtained from the patient).
Patent AU-2019351255-A1 (AU)
Title: Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy
Inventor: NAKAO SHINSUKE
IPC: A61K35/768
Filed: 2019-09-25
Abstract: The present invention provides: a combination therapy in which a recombinant vaccinia virus (in particular, oncolytic vaccinia virus) used to treat cancers, and another cancer therapy are combined; and a pharmaceutical composition and a combination kit for use in the combination therapy. More specifically, provided are: a therapy in which an immune checkpoint inhibitor and a vaccinia virus which includes a polynucleotide that encodes interleukin-7 (IL-7) and a polynucleotide that encodes interleukin-12 (IL-12) are used in combination; and a pharmaceutical composition and a combination kit used in the therapy.
Patent AU-2019356573-A1 (AU)
Title: PD-1 single domain antibodies and therapeutic compositions thereof
Inventor: Pandit Rajay
IPC: C07K16/28
Filed: 2019-10-11
Abstract: Provided herein are binding polypeptides that specifically bind PD-1. More specifically, provided herein are fusion proteins, including multivalent and/or multispecific constructs and chimeric antigen receptors, that bind PD-1. Also provided are pharmaceutical compositions containing the polypeptides, nucleic acid molecules encoding the polypeptides and vectors and cells thereof, and methods of use and uses of the provided PD-1 binding polypeptides for treating diseases and conditions, such as cancer.
Patent AU-2019371072-A1 (AU)
Title: Radiomic signature of an epicardial region
Inventor: ANTONIADES CHARALAMBOS
IPC: A61B6/00
Filed: 2019-10-29
Abstract: A method for characterising an epicardial region using medical imaging data, e.g. Gray-level co-occurrence matrix, of a subject. The method comprises calculating the value of an epicardial radiomic signature of the epicardial region using the medical imaging data. Also disclosed is a method for deriving an epicardial radiomic signature indicative of cardiac health. The method comprises using a radiomic dataset to construct an epicardial radiomic signature. Also disclosed are systems for performing the aforementioned methods.
Patent AU-2019384557-A1 (AU)
Title: Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR
Inventor: KARVE SHRIRANG
IPC: A61K38/17
Filed: 2019-11-21
Abstract: The present invention provides, among other things, an improved method of treating cystic fibrosis (CF) in a human subject. The method comprises administering a composition comprising an mRNA encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein at a concentration of 0.5 mg/mL or greater to a human subject via nebulization. The composition is aerosolized using a nebulizer and a nominal dose of the mRNA is administered to the human subject via the nebulizer over a period of time, typically at least 30 minutes, at a suitable nebulization rate,